Roll out of the COVID:19 vaccine programme

Public Accounts Committee Closed Inquiry
Opened: 26 Jan 2022 Closed: 8 Nov 2022 Parliament page
This inquiry follows on from our February 2021 report on the development and rollout of the first vaccines in the UK The Committee will question senior officials at DHSC, NHS England and the UK Health Security Agency on how well placed the government is to meet its full objectives for … Read more
17 Recommendations
15 Conclusions
1 Report
1 Oral session
2 Letters
1 Event
Activity timeline 6 events
8 Nov
2022
Report published
8 Nov
2022
Correspondence
13 Jul
2022
Report published
12 May
2022
Correspondence
28 Mar
2022
Oral evidence
28 Mar
2022
Formal meeting (oral evidence session) · Room 8, Palace of Westminster
Oral evidence sessions 1 session
28 Mar 2022
View on parliament.uk
Roll out of the COVID:19 vaccine programme
Amanda Pritchard · NHS England Dame Dr Emily Lawson · NHS England and NHS Improvement Dr Jenny Harries OBE · UK Health Security Agency Madelaine McTernan · Department for Business, Energy and Industrial Strategy Shona Dunn · Home Office
Title HC No. Published Items Response
Eleventh Report - The rollout of the COVID-19 vaccine programme … HC 258 13 Jul 2022 32 Responded
Recommendations & Conclusions
7 results
Clear
5 Recommendation Rejected
Eleventh Report - The rollout of t…
After starting with a portfolio of seven candidates, the UK’s vaccine supply for 2022 and...
After starting with a portfolio of seven candidates, the UK’s vaccine supply for 2022 and 2023 now relies primarily on just two, yet many of the risks that the ‘portfolio’ approach was intended to mitigate remain. The UK’s portfolio strategy … Read more
Government Response
The government disagrees with the recommendation to review the future procurement strategy for COVID-19 vaccines, stating that the current strategy is kept under constant review with expert advice. They cite agreements with developers that give access to updated vaccines and bivalent vaccines having received regulatory approval.
HM Treasury
View details
10 Recommendation Rejected
Eleventh Report - The rollout of t…
The vaccine programme still has some issues to address.
The vaccine programme still has some issues to address. In England, 2.98 million adults were still unvaccinated at the end of May 2022. Analysis by UKHSA has confirmed that full and booster vaccination reduces the risk of someone falling seriously … Read more
Government Response
The government disagrees with the recommendation to set a challenge to reduce the number of unvaccinated adults to 2.5 million and achieve 80% booster uptake, arguing it is moving away from target-based approaches.
HM Treasury
View details
11 Recommendation Rejected
Eleventh Report - The rollout of t…
We asked officials about their strategy with regard to the unvaccinated.
We asked officials about their strategy with regard to the unvaccinated. UKHSA and NHS England told us that the basic public health message remained clear—that everyone was encouraged to get vaccinated—and that they continued to work with local government, local … Read more
Government Response
The government disagrees with the Committee's recommendation to reduce the number of unvaccinated adults to 2.5 million, stating that it will continue to focus on reaching out to the unvaccinated but will move away from setting targets.
HM Treasury
View details
12 Recommendation Rejected
Eleventh Report - The rollout of t…
NHS England said it had built on approaches recommended by the Scientific Advisory Group for...
NHS England said it had built on approaches recommended by the Scientific Advisory Group for Emergencies and the World Health Organisation to achieve the excellent uptake to date.27 But it acknowledged that the country was no longer in a state … Read more
Government Response
The government disagrees with the Committee's recommendation to reduce the number of unvaccinated adults to 2.5 million, stating that it will continue to focus on reaching out to the unvaccinated but will move away from setting targets.
HM Treasury
View details
19 Recommendation Rejected
Eleventh Report - The rollout of t…
Since then, out of the original portfolio of seven candidates, six have been approved for...
Since then, out of the original portfolio of seven candidates, six have been approved for use in the UK to date.44 But with six vaccines to choose from, it is noteworthy that only three—AstraZeneca, Pfizer and Moderna—have actually been deployed … Read more
Government Response
The government disagrees with the recommendation to review the future procurement strategy for COVID-19 vaccines, stating that the current strategy is kept under constant review with expert advice. They cite agreements with developers that give access to updated vaccines and bivalent vaccines having received regulatory approval.
HM Treasury
View details
20 Recommendation Rejected
Eleventh Report - The rollout of t…
In our assessment, many of the risks that the portfolio approach was intended to mitigate...
In our assessment, many of the risks that the portfolio approach was intended to mitigate remain. Most notable among these is the risk that future variants of the virus may respond better to one vaccine than another, perhaps a vaccine … Read more
Government Response
The government disagrees with the recommendation, stating that the portfolio approach was the right strategy in the early stages of the pandemic, and the vaccine procurement strategy is kept under constant review.
HM Treasury
View details
21 Recommendation Rejected
Eleventh Report - The rollout of t…
The Taskforce also told us that the COVID-19 vaccine market was still developing and that...
The Taskforce also told us that the COVID-19 vaccine market was still developing and that it considered many different factors when deciding which vaccines to procure, including the evolution of the virus and improved learning about different types of vaccines … Read more
Government Response
The government disagrees with the recommendation to review the future procurement strategy for COVID-19 vaccines, arguing that the current portfolio approach is constantly reviewed with clinical and commercial expertise.
HM Treasury
View details
Government Response AI assessment · 21 of 17 classified
Accepted 12
Not Addressed 2
Rejected 7
Total 17 recs + 15 conclusions
Correspondence 2 letters
8 Nov 2022 Correspondence from Amanda Pritchard, Chief Executive, NHS England, re House of Commons Committee of Public Accounts Eleventh Report of Sessions 2022- 2023: The rollout of the COVID-19 vaccine programme in England, dated 31 October 2022
Parliament page
12 May 2022 Correspondence from Amanda Pritchard, Chief Executive, NHS, re Follow up to the Public Accounts Committee oral evidence session on COVID-19 vaccines – 28 March 2022, dated 22 April 2022
Parliament page